ArticleCadernos de saude publica2026
Dengue virus introduction and 2025 outlook: scenario-based evaluation of vaccination impact using mathematical modeling.
Article in Cadernos de saude publica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aims to model multiple scenarios of dengue introduction and spread in Botucatu, São Paulo State, Brazil, and to evaluate the impact of vaccination strategies on the epidemic trajectory in a city that, until 2023, had less than 1% of its population infected with dengue. First, we estimated the basic reproduction number (R 0 ) during the 2024 epidemic and compared it with values reported in the literature. We then developed an age-stratified mathematical model, calibrated to 2024 dengue case data using a genetic algorithm, to simulate transmission dynamics with and without vaccination. This approach enabled us to assess the potential reduction in infections under various immunization scenarios. The estimated R 0 for the 2024 epidemic was 1.57, resulting in an attack rate exceeding 10% of the population. Our model accurately fits the observed data and suggests that, under conditions similar to those of 2024, the introduction of a new serotype in 2025 would likely trigger another epidemic. Vaccination could reduce this peak by up to 80%, depending on coverage among individuals aged 10-14 years. The results indicate that the R 0 of dengue estimated for Botucatu in 2024 is consistent with values reported for other Brazilian cities. The vaccination campaign shows the potential to reduce dengue cases by 75% or more. However, since campaign effectiveness depends on the circulating serotype and the epidemiological status of vaccinated individuals, achieving vaccination coverage above 50% in the target population is essential to avoid the need for individual epidemiological screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.